Nakamoto (NAKA) vs P3 Health Partners (PIII)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
P3 Health Partners (PIII) has outperformed Nakamoto (NAKA) over the past year, losing 70.4% versus a loss of 80.6%. P3 Health Partners is the larger company by market cap ($350.2 million vs $63.1 million), about 5.5 times the size. P3 Health Partners converts more of its revenue into profit, with a net margin of -10.1% versus -2867.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NAKA | PIII |
|---|---|---|
| Share price | $3.44 | $1.69 |
| Market cap | $63.11M | $350.24M |
| 1-day change | -15.89% | -9.14% |
| YTD return | -75.50% | -51.58% |
| 1-year return | -80.59% | -70.40% |
| 5-year return | — | -99.66% |
| P/E ratio (TTM) | 0.14 | — |
| EPS (TTM) | $24.06 | $-23.21 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.82M | $1.46B |
| Revenue growth (YoY) | -33.04% | -2.76% |
| Net income (latest FY) | $-52.23M | $-147.95M |
| Operating margin | -10824.01% | -18.53% |
| Net margin | -2867.65% | -10.14% |
| 52-week high | $23.20 | $16.89 |
| 52-week low | $3.33 | $1.52 |
| Distance from 52-week high | -85.17% | -89.99% |
| Analyst consensus | none | buy |
| Avg. price target upside | +287.50% | +358.58% |
| Average volume | 197.37K | 30.85K |
| Shares outstanding | 18.35M | 4.02M |
| Employees | 33 | 320 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- P3 Health Partners is about 5.5 times larger than Nakamoto by market value ($350.24M vs $63.11M).
- PIII has outperformed NAKA by 10.2 percentage points over the past year.
- P3 Health Partners is more profitable, keeping -10.1 cents of every revenue dollar as net income versus -2867.6 cents for Nakamoto.
- P3 Health Partners grew revenue faster in its latest fiscal year (-2.76% vs -33.04%).
About Nakamoto
NAKA stock →Nakamoto Inc. develops and invests in a global portfolio of Bitcoin-native companies.
Health Care · Medical/Nursing Services · 33 employees
About P3 Health Partners
PIII stock →P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers.
Health Care · Medical/Nursing Services · 320 employees
NAKA vs PIII FAQ
Which is bigger, Nakamoto or P3 Health Partners?
P3 Health Partners (PIII) is larger, with a market capitalization of $350.24M compared with $63.11M for Nakamoto (NAKA).
Which stock has performed better over the past year, NAKA or PIII?
PIII returned -70.40% over the past 12 months, compared with -80.59% for NAKA (price return, excluding dividends). Past performance does not predict future results.
Are Nakamoto and P3 Health Partners in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.